Evaluation of translymphatic chemotherapy targeting sentinel lymph nodes of patients with oral cancer using intra-arterial chemotherapy.

Evaluation of translymphatic chemotherapy targeting sentinel lymph nodes of patients with oral cancer using intra-arterial chemotherapy. - oral cancer lymphatic chemotherapy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007038

Enrollment

Registered

2012-01-10

Start date

2011-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral cancer

Interventions

lymphatic chemotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Untreated oral squamous cell carcinoma (T2 orT3) patients with small neck metastasis (about 1cm).

Exclusion criteria

Exclusion criteria: 1) distant metastasis 2) previously treated patients 3) A history of radiation therapy for the neck 4) pregnancy or lactating women or women with suspected pregnancy 5) Patients judged by the investigator to be unfit to be enrolled into the study

Design outcomes

Primary

Measure	Time frame
Evaluate CDDP concentration in SNL	—

Countries

Japan

Contacts

Public ContactShin Ito

Juntendo University school of medicine Department of Otolaryngology, head and neck surgery

shin709@juntendo.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026